Your heart works on a lipid system. Cholesterol moves through your blood on particles, those particles are made of fat, and fat oxidizes. That single fact explains why an antioxidant that lives inside fat has drawn so much cardiovascular research.
Astaxanthin is that antioxidant. It is the red carotenoid that gives salmon and flamingos their colour, and it comes from the microalga Haematococcus pluvialis. Researchers have now run more than a dozen randomized controlled trials looking at astaxanthin and cholesterol, triglycerides, inflammation and blood pressure.
This guide covers six benefits that human trials support, with the numbers, the doses and the timelines behind each one.
New to this molecule? Start with our overview of astaxanthin benefits and health effects, then come back here for the cardiovascular detail.
Astaxanthin raises HDL cholesterol and lowers triglycerides in human trials at 12 mg per day and above. It also protects LDL from oxidation and lowers CRP, a marker of inflammation. In people with dyslipidemia or prediabetes, LDL and total cholesterol fall as well.
Here is the pooled picture from trials using 6 to 20 mg per day.
| Marker | Effect in human trials | Strength of evidence |
|---|---|---|
| HDL cholesterol | Increases | Consistent across 3 meta-analyses |
| Triglycerides | Decreases at 12 to 18 mg/day | Consistent |
| Oxidized LDL | Decreases, dose-dependent | Consistent, small trials |
| CRP (inflammation) | Decreases above 12 mg/day after 12 weeks | Moderate |
| Blood flow | Transit time shortens | Moderate |
Six benefits come out of that table. Here is each one.
HDL is the particle that carries cholesterol away from your artery walls and back to your liver. Higher HDL is generally better.
This is the most reproducible finding in the whole cardiovascular literature on astaxanthin.
A 2025 systematic review and meta-analysis in Pharmaceuticals pooled eight randomized controlled trials at 6 to 20 mg per day. HDL rose significantly (SMD 0.42, 95% CI 0.11 to 0.73). In the groups taking 12 mg per day, HDL went from 55 mg/dL to 63 mg/dL.
An earlier meta-analysis of 14 trials found the same direction with a smaller average gain of 1.47 mg/dL across mixed populations.
Yoshida's 2010 trial in Atherosclerosis adds a useful detail. In 61 adults with mild hyperlipidemia, HDL rose at 6 mg and at 12 mg per day over 12 weeks. Adiponectin rose too, a hormone that helps regulate fat and glucose metabolism.
So HDL responds at doses as low as 6 mg. That is the entry point for this benefit.
Triglycerides are the fats circulating in your blood between meals. High levels track with cardiovascular risk.
In the 2025 meta-analysis, triglycerides fell significantly (SMD −0.31, 95% CI −0.51 to −0.10). At 18 mg per day, they dropped from 151 mg/dL to 112 mg/dL.
Dose is the deciding factor here. In Yoshida's trial, triglycerides fell at 12 mg and at 18 mg. They did not fall at 6 mg. A 2026 meta-analysis in people with prediabetes and type 2 diabetes found triglycerides down by about 21 mg/dL.
The pattern is simple. HDL responds at 6 mg. Triglycerides need 12 mg or more.
This is the benefit almost no consumer article covers, and it may be the most interesting one.
Your LDL number tells you how much LDL is in your blood. It does not tell you what condition that LDL is in. LDL only becomes a problem for your artery wall after free radicals damage it. Oxidized LDL is what immune cells absorb, and that absorption is how foam cells and plaque begin.
Astaxanthin is built for this job. Its molecular structure carries polar groups at both ends of a long carbon chain, so it spans the cell membrane rather than sitting in one layer of it. That position lets it intercept free radicals at the exact place where lipid oxidation starts.
Iwamoto's 2000 study in the Journal of Atherosclerosis and Thrombosis tested doses from 1.8 to 21.6 mg per day and found that astaxanthin extended the time it took for LDL to oxidize, in a dose-dependent way.
Preclinical work adds a second mechanism. In cell and animal models, astaxanthin promotes cholesterol efflux from macrophages by upregulating the ABCA1 transporter, the first step in moving cholesterol back to the liver. That research has not been confirmed in humans, so treat it as a research lead rather than a finding.
To understand why this molecule handles oxidation better than most, read our comparison of the most potent antioxidants and their sources.
Oxidation and inflammation drive the same arterial process. CRP is the standard blood marker for the second half of it.
The 2020 meta-analysis of 14 trials found CRP fell under two conditions. When astaxanthin was taken for 12 weeks or longer, CRP dropped by 0.53 mg/L. When the dose exceeded 12 mg per day, it dropped by 0.39 mg/L.
Both conditions matter. Short courses at low doses did nothing to CRP. Longer courses at higher doses did.
The 2023 trial in adults with prediabetes also improved three separate cardiovascular risk markers: fibrinogen, L-selectin and fetuin-A.
This inflammatory pathway is the same one behind astaxanthin's work on ageing. We covered that connection in how astaxanthin acts on inflammaging.
Your endothelium is the single-cell lining of your blood vessels. It releases nitric oxide, which tells vessels when to relax. Oxidative stress damages that lining and blunts the signal.
Astaxanthin protects endothelial cells from oxidative damage. Human trials show shorter blood transit times, meaning blood moves through capillaries more easily. One study reported a measurable improvement after 10 days at 6 mg per day.
This is also why astaxanthin appears in sports nutrition, where oxygen delivery and recovery are the goal. Our review of astaxanthin for athletes covers that research.
The LDL question has a clear answer, and it depends on where you start.
A 2023 randomized trial in Diabetes, Obesity and Metabolism gave 12 mg of astaxanthin daily to 34 adults with prediabetes and dyslipidemia for 24 weeks. LDL fell by 0.33 mmol/L, roughly 13 mg/dL. Total cholesterol fell by 0.30 mmol/L, roughly 12 mg/dL. Both reached statistical significance. HDL rose significantly as a percentage change from baseline.
The 2026 meta-analysis in prediabetes and type 2 diabetes found total cholesterol down by about 12 mg/dL, matching that direction.
The 2023 trial deserves one caveat. Its primary endpoint did not reach the significance level the researchers set in advance, and the sample was small. The findings are promising rather than settled.
Cardiovascular risk climbs for women after menopause, partly because oxidative stress rises as oestrogen falls. That makes this group worth watching. We reviewed the evidence in astaxanthin for women.
The trials that produced these results cluster in a narrow range.
Two practical points. Astaxanthin is fat-soluble, so take it with a meal containing fat. And give it time. If you stop at four weeks, you stopped before any trial found anything.
On safety, the 24-week trial at 12 mg per day reported no clinically apparent side effects. The FDA has accepted daily doses of 2 to 12 mg in supplements, and up to 24 mg for periods of no longer than 30 days.
The research above has a condition attached that is easy to miss.
Every trial in this article used natural astaxanthin from Haematococcus pluvialis. Synthetic astaxanthin, made from petrochemicals, has a different stereoisomer profile. These results do not transfer to it. We explain the difference in natural vs. synthetic astaxanthin.
Production method matters too. Open pond cultivation exposes the algae to weather, contamination and inconsistent light, which shows up as batch-to-batch variation in astaxanthin content and stability. Closed photobioreactors control the growing conditions instead.
At axabio®, we grow Haematococcus pluvialis in patented 4th-generation flat-panel photobioreactors in Hemiksem, Belgium, and extract with supercritical CO₂. No solvents. The result is a natural astaxanthin oleoresin with consistent potency batch after batch. If you are comparing suppliers, our technology-based comparison of astaxanthin producers sets out how the methods differ.
Three things to check on any label:
Astaxanthin has real benefits for heart health, and they are specific. HDL rises. Triglycerides fall at 12 mg and above. LDL resists oxidation. CRP comes down over 12 weeks. Blood flows more easily. In people carrying dyslipidemia or prediabetes, LDL and total cholesterol improve as well.
Those benefits come from one property: astaxanthin protects fats from oxidation, from inside the membrane where oxidation begins. That is what it is good at, and the cardiovascular research keeps pointing back to it.
If you formulate supplements and want a natural astaxanthin with consistent potency and stability behind it, see the axabio® ingredient range or talk to our team about your formulation.
Fornari Laurindo L, Dogani Rodrigues V, Penna Carneiro D, et al. Assessing the effects of moderate to high dosage of astaxanthin supplementation on lipid profile parameters: a systematic review and meta-analysis of randomized controlled studies. Pharmaceuticals (Basel). 2025;18(8):1097. doi:10.3390/ph18081097
Xia W, Tang N, Kord-Varkaneh H, Low TY, Tan SC, Wu X, Zhu Y. The effects of astaxanthin supplementation on obesity, blood pressure, CRP, glycemic biomarkers, and lipid profile: a meta-analysis of randomized controlled trials. Pharmacological Research. 2020;161:105113. doi:10.1016/j.phrs.2020.105113
Yoshida H, Yanai H, Ito K, Tomono Y, Koikeda T, Tsukahara H, Tada N. Administration of natural astaxanthin increases serum HDL-cholesterol and adiponectin in subjects with mild hyperlipidemia. Atherosclerosis. 2010;209(2):520-523. doi:10.1016/j.atherosclerosis.2009.10.012